Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM
Status:
Completed
Trial end date:
2018-08-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of Naoxintong Capsule in the
secondary prevention of ischemic stroke by the multi-center,
randomized,double-blind，placebo-controlled trial design project.
Phase:
Phase 4
Details
Lead Sponsor:
Xiaofei Yu
Collaborator:
Shanghai Municipal Science and Technology Commission